Wikisage, the free encyclopedia of the second generation, is digital heritage
Zollinger-Ellinson syndrome: Difference between revisions
Jump to navigation
Jump to search
m (→Links) |
(n) |
||
| Line 6: | Line 6: | ||
*Sunil Dasha et al. 2015 [http://gastro.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=25698559 Gastroenterol. Rep. 1-8] | *Sunil Dasha et al. 2015 [http://gastro.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=25698559 Gastroenterol. Rep. 1-8] | ||
[[nl:Syndroom van | [[nl:Syndroom van Zollinger-Ellinson]] | ||
Revision as of 23:17, 26 July 2015
Zollinger–Ellison Syndrome (ZES) is caused by a non–beta islet cell (islet of Langerhans), gastrin-secreting tumor of the pancreas that stimulates the acid-secreting cells of the stomach (parietal cells) to maximal activity, with consequent gastrointestinal mucosal ulceration. ZES may occur sporadically or as part of an autosomal dominant familial syndrome called multiple endocrine neoplasia type 1 (MEN 1). The primary tumor is usually located in the pancreas, duodenum or abdominal lymph nodes, but ectopic locations have also been described (e.g., heart, ovary, gallbladder, liver, kidney).
Links
- Sara Massironi 2015 Somatostatin analogs for gastric carcinoids: for many, but not all World J Gastroenterol. ; 21(22): 6785–6793
- Sunil Dasha et al. 2015 Gastroenterol. Rep. 1-8